fbpx
The website is currently undergoing scheduled maintenance. All transactions are offline. We apologise for the inconvenience.

Quick facts about oligoarticular-persistent JIA

Oligoarticular-persistent arthritis affects more females than males. It affects four or fewer joints. There may also be inflammation in the eye, called uveitis.

Oligoarticular-persistent arthritis affects more females than males. It affects four or fewer joints. There may also be inflammation in the eye, called uveitis.

• Oligoarticular-persistent arthritis is generally the mildest form of JIA

• It affects girls more often than boys.

• It usually begins before four years of age.

• It most often affects the large joints such as the knee, ankle, wrist, and/or elbow joints.

• It can be associated with an eye disease called uveitis, which affects up to 20% of young people with this type of JIA.

It is rare to have permanent joint damage with appropriate treatment of this type of JIA. Sometimes this type of JIA goes away completely a few years after their symptoms begin. For others, the disease may last into adulthood.


Quick facts about oligoarticular-extended JIA

Oligoarticular-extended arthritis occurs in females more often than males. It affects both large and small joints asymmetrically. There may be inflammation in the eye, called uveitis.

Oligoarticular-extended arthritis occurs in females more often than males. It affects both large and small joints asymmetrically. There may be inflammation in the eye, called uveitis.

This type of JIA also affects four or fewer joints in the first six months after diagnosis. However, after six months or more, patients with oligoarticular-extended arthritis develop arthritis in five or more joints.

Here are a few facts about oligoarticular-extended JIA:

• Approximately 25% of children who start out with oligoarticular JIA will develop extended arthritis in more than four joints at some point.
• Oligoarticular-extended JIA can affect both large and small joints.
• This type of arthritis is often treated with disease-modifying anti-rheumatic drugs (DMARDs) and biologic medication to control the joint inflammation

Cart

No products in the cart.
Skip to content